As of October 2024, Immunicum AB has a market cap of $684.70M. This makes Immunicum AB the world's 9672th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $36.78M | -16.83% |
2023 | $44.22M | -78.30% |
2022 | $203.77M | -43.76% |
2021 | $362.30M | -42.09% |
2020 | $625.68M | -29.66% |
2019 | $889.49M | 41.40% |
2018 | $629.07M | 7.23% |
2017 | $586.65M | -69.83% |
2016 | $1.94B | -35.96% |
2015 | $3.04B | 81.82% |
2014 | $1.67B | -28.86% |
2013 | $2.35B | - |